Finian McGrath
Question:1036. Deputy Finian McGrath asked the Minister for Health if he will support the new drug for Cystic Fibrosis patients (details supplied) [47802/12]
View answerTuesday, 6 November 2012
Questions (1036)
Written answers
The HSE recently received an application for Kalydeco's inclusion under the Community Drugs Scheme. In accordance with normal procedures, the National Centre for Pharmacoeconomics must conduct a Health Technology Assessment (HTA) on this product which will consider if the drug is cost effective at the price offered to the HSE. No reimbursement decision will be made until the HTA has been completed.